Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2010
04/15/2010CA2755968A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof
04/15/2010CA2752429A1 Chewable gelled emulsions
04/15/2010CA2742966A1 Chewable gelled emulsions
04/15/2010CA2742902A1 New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer
04/15/2010CA2740772A1 Indazole compounds
04/15/2010CA2740148A1 Activators of human pyruvate kinase
04/15/2010CA2740124A1 Use of scyllo-inositols for the treatment of macular degeneration-related disorders
04/15/2010CA2740099A1 Method of inducing negative chemotaxis
04/15/2010CA2740087A1 Gaba conjugates and methods of use thereof
04/15/2010CA2740075A1 Combination therapy comprising angiotensin receptor blockers and vasopressin receptor antagonists
04/15/2010CA2740035A1 Novel combinations of antibacterial nitrogenous heterocyclic compounds with other antibacterial compounds, and use thereof as drugs
04/15/2010CA2740011A1 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3)
04/15/2010CA2740005A1 Transdermal delivery
04/15/2010CA2740003A1 Pyrone analogs for therapeutic treatment
04/15/2010CA2739948A1 Treating hepatitis c virus infection with over-expression of microrna-196
04/15/2010CA2739897A1 Aerosol fluoroquinolone formulations for improved pharmacokinetics
04/15/2010CA2739893A1 Inhalation of levofloxacin for reducing lung inflammation
04/15/2010CA2739887A1 Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
04/15/2010CA2739877A1 The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof
04/15/2010CA2739875A1 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
04/15/2010CA2739822A1 Liposomal systems comprising sphingomyelin
04/15/2010CA2739788A1 Telomerase inhibitors that bind to the cr4-cr5 domain of the rna component of human telomerase and methods of use thereof
04/15/2010CA2739787A1 .beta.-hydroxy-.gamma.-aminophosphonates and methods for the preparation and use thereof
04/15/2010CA2739782A1 Imidazopyridazinecarbonitriles useful as kinase inhibitors
04/15/2010CA2739776A1 Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents
04/15/2010CA2739715A1 Treating or preventing gout
04/15/2010CA2739673A1 New amide compounds as boosters of antivirals
04/15/2010CA2739658A1 Composition and method for treating dry eye syndrome
04/15/2010CA2739559A1 Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof
04/15/2010CA2739546A1 Polysaccharides containing carboxyl functional groups substituted by a hydrophobic alcohol derivative
04/15/2010CA2739527A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
04/15/2010CA2739380A1 Amorphous rotigotine transdermal system
04/15/2010CA2739373A1 Tricyclic oxazolidinone antibiotic compounds
04/15/2010CA2739353A1 Corticosteroid compositions and methods of treatments thereof
04/15/2010CA2739342A1 Oxazolidinyl antibiotics
04/15/2010CA2739246A1 Sustained release drug delivery system
04/15/2010CA2739078A1 Biodegradable polymer - bioactive moiety conjugates
04/15/2010CA2738875A1 Antiprolactinic veterinary composition for ruminants
04/15/2010CA2738870A1 Pyrrolidine n-benzyl derivatives
04/15/2010CA2738831A1 Tacrolimus preparation for external applications
04/15/2010CA2738816A1 Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
04/15/2010CA2738814A1 Hiv integrase inhibitors
04/15/2010CA2738775A1 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
04/15/2010CA2738630A1 Methods for treating or preventing pain using spicamycin derivatives
04/15/2010CA2738214A1 Chewing gum containing low dose amounts of water soluble vitamins
04/15/2010CA2737684A1 Oral vaccines for producing mucosal immunity
04/15/2010CA2737391A1 Liquid pharmaceutical formulation containing paracetamol
04/15/2010CA2737255A1 Modified release emulsions for application to skin or vaginal mucosa
04/15/2010CA2737102A1 Benzimidazole anthelmintic compositions
04/15/2010CA2736930A1 1-phenylpyrrole compounds
04/15/2010CA2736924A1 Modulators for amyloid beta
04/15/2010CA2736923A1 Atropisomers of (hydroxyalkyl) pyrrole derivatives
04/15/2010CA2736861A1 18f-labelled folates as pet radiotracers
04/15/2010CA2736433A1 Natural preservative alternatives and compositions containing same
04/15/2010CA2736322A1 3,3', 4,4'-tetrahydroxy-2,2' -bipyridine-n,n' -dioxides for the treatment of renal cell carcinoma
04/15/2010CA2736097A1 Carbazole compounds and therapeutic uses of the compounds
04/15/2010CA2735962A1 Crosslinked polymers
04/15/2010CA2733262A1 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
04/14/2010EP2174972A1 Alkylene oxide derivative and skin external preparation containing the same
04/14/2010EP2174953A1 Compositions and methods for the diagnosis and treatment of tumor
04/14/2010EP2174945A1 Antisense modulation of apolipoprotein B expression
04/14/2010EP2174944A1 Polyene diester antibiotics
04/14/2010EP2174940A1 Process for production of optically active mirtazapine
04/14/2010EP2174939A1 Pyranones useful as ATM inhibitors
04/14/2010EP2174936A1 PNA monomer and precursor
04/14/2010EP2174935A1 Linezolid Compositions
04/14/2010EP2174930A1 Antitumor agent comprising sulfostin and sulfostin-related compound as the active ingredient
04/14/2010EP2174690A1 Preparation with a combination of cinnarizine and dimenhydrinate for treating dizziness
04/14/2010EP2174667A1 Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient
04/14/2010EP2174666A1 Medicinal agent for prevention or treatment of alzheimer's disease
04/14/2010EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof
04/14/2010EP2174658A1 Compositions comprising nebivolol
04/14/2010EP2174651A1 A polymer-free hydrogel
04/14/2010EP2174650A1 Modified release emulsions for application to skin or vaginal mucosa
04/14/2010EP2174647A1 Gel-like composition for external application comprising adenine compound
04/14/2010EP2173912A2 Novel synthetic agonists of tlr9
04/14/2010EP2173911A2 Methods for reverting methylation by targeting dnmt3a and dnmt3b
04/14/2010EP2173904A1 Nanoassembled complexes of nucleic acids, avidin and polymers, use and preparation thereof
04/14/2010EP2173891A2 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
04/14/2010EP2173876A2 T-cell cytokine-inducing surface molecules and methods of use
04/14/2010EP2173759A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses
04/14/2010EP2173756A2 Macrolactone derivatives
04/14/2010EP2173752A2 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrroloý2,3-d¨pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
04/14/2010EP2173750A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
04/14/2010EP2173749A1 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents
04/14/2010EP2173748A2 Indolyl pyrrolidines for the treatment of cancer
04/14/2010EP2173744A1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
04/14/2010EP2173743A2 Sodium channel inhibitors
04/14/2010EP2173739A1 Substituted cc-1065 analogs and their conjugates
04/14/2010EP2173737A1 Method for modulating gpr119 g protein-coupled receptor and selected compounds
04/14/2010EP2173734A2 Chemical compounds
04/14/2010EP2173733A2 Compositions and methods comprising analogues of radicicol a
04/14/2010EP2173732A2 Docetaxel process and polymorphs
04/14/2010EP2173730A1 Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates
04/14/2010EP2173728A2 Heterocyclic modulators of pkb
04/14/2010EP2173724A2 Quinazolinone compounds and methods of use thereof
04/14/2010EP2173723A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
04/14/2010EP2173722A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
04/14/2010EP2173720A2 2-imidazolines having a good affinity to the trace amine associated receptors (taars)
04/14/2010EP2173719A1 4-imidazolines and their use as antidepressants
1 ... 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 ... 7860